Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer

Clinical trial NCT02194049 · COMPLETED

Trial details

NCT number: NCT02194049
Sponsor: University of California, Davis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Extensive Stage Small Cell Lung Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2014-07-01
Primary completion: 2016-04-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.